Sominex

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:sleepwear
gptkbp:approves 1960s
gptkbp:available_in liquid form
over-the-counter
chewable tablets
gptkbp:brand gptkb:Sominex
gptkbp:clinical_trial safety and efficacy
sleep quality improvement
dosage optimization
side effects monitoring
gptkbp:contraindication gptkb:asthma
gptkb:Ophthalmology
pregnancy
breastfeeding
gptkbp:dosage_form 50 mg
gptkbp:formulation gptkb:tablet
gptkb:liquid
https://www.w3.org/2000/01/rdf-schema#label Sominex
gptkbp:ingredients gptkb:diphenhydramine
sucrose
sodium
flavoring agents
coloring agents
gptkbp:interacts_with gptkb:beer
antihistamines
antidepressants
other sedatives
gptkbp:invention patented
generic available
gptkbp:is_recommended_for adults
children over 12
gptkbp:manufacturer gptkb:Chattem,_Inc.
gptkbp:marketed_as gptkb:Australia
gptkb:Canada
gptkb:New_Zealand
gptkb:United_Kingdom
gptkb:United_States
gptkbp:packaging gptkb:bottle
blister pack
gptkbp:related_products gptkb:Zzz_Quil
gptkb:Benadryl
gptkbp:shelf_life 2 years
gptkbp:side_effect dizziness
drowsiness
dry mouth
gptkbp:storage room temperature
dry place
gptkbp:suitable_for elderly
children under 12
gptkbp:symptoms confusion
seizures
hallucinations
rapid heart rate
gptkbp:used_for insomnia
gptkbp:bfsParent gptkb:Pfizer_Consumer_Healthcare
gptkbp:bfsLayer 5